Quanta Therapeutics, Inc.

CIK 1891891 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Quanta Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jun 24, 2026D/A0001891891-26-000002
May 25, 2023D0001891891-23-000002
Feb 17, 2023D0001891891-23-000001
Nov 3, 2021D0001891891-21-000001